Gene · 51548
Papers4,574
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 4,574
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SIRT6 alleviates senescence induced by Porphyromonas gingivalis in human gingival fibroblasts. | Mol Biol Rep | 2024 | 39259343 | PubTator, text mining | PubMed |
| Inhibition of Sirtuin Deacylase Activity by Peroxynitrite. | Biochemistry | 2024 | 39256054 | PubTator, text mining | PubMed |
| On the interface of aging, cancer, and neurodegeneration with SIRT6 and L1 retrotransposon protein interaction network. | Ageing Res Rev | 2024 | 39251041 | PubTator, text mining | PubMed |
| In vitro maturation using porcine follicular fluid-derived exosomes as an alternative to the conventional method. | Theriogenology | 2024 | 39243630 | PubTator, text mining | PubMed |
| Effects of Nicotinamide Adenine Dinucleotide on Older Patients with Heart Failure. | Rev Cardiovasc Med | 2024 | 39228487 | PubTator, text mining | PubMed |
| MitoAMPK inhibits the Warburg effect by MZF1-SIRT6 with glycosis related genes in NSCLC. | J Cell Mol Med | 2024 | 39224032 | PubTator, text mining | PubMed |
| SIRT6 prevent chronic cerebral hypoperfusion induced cognitive impairment by remodeling mitochondrial dynamics in a STAT5-PGAM5-Drp1 dependent manner. | J Transl Med | 2024 | 39183280 | PubTator, text mining | PubMed |
| Research advances on silence information regulator 6 as a potential therapeutic target for bone regeneration and repair. | Zhejiang Da Xue Xue Bao Yi Xue Ban | 2024 | 39183069 | PubTator, text mining | PubMed |
| Serum Sirt6 as a Potential Biomarker for Osteoarthritis and its Correlation with IL-6 Alterations. | Indian J Orthop | 2024 | 39170662 | PubTator, text mining | PubMed |
| Effect and mechanism of curcumin on colon cancer cell senescence through early growth response 1 (EGR1). | Transl Cancer Res | 2024 | 39145095 | PubTator, text mining | PubMed |
| Assessment of Metabolic, Inflammatory, and Immunological Disorders Using a New Panel of Plasma Parameters in People Living with HIV Undergoing Antiretroviral Therapy-A Retrospective Study. | J Clin Med | 2024 | 39124846 | PubTator, text mining | PubMed |
| Ageing-related bone and immunity changes: insights into the complex interplay between the skeleton and the immune system. | Bone Res | 2024 | 39103328 | PubTator, text mining | PubMed |
| Correlation of MicroRNA-125b, Sirtuin, and Signal Transducer and Activator of Transcription 3 with Biochemical Parameters and Risk Factors in Atherosclerosis Patients. | Rep Biochem Mol Biol | 2024 | 39086582 | PubTator, text mining | PubMed |
| Sirt6 overexpression relieves ferroptosis and delays the progression of diabetic nephropathy via Nrf2/GPX4 pathway. | Ren Fail | 2024 | 39082470 | PubTator, text mining | PubMed |
| Cysteine-rich 61 inhibition attenuates hepatic insulin resistance and improves lipid metabolism in high-fat diet fed mice and HepG2 cells. | FASEB J | 2024 | 39082187 | PubTator, text mining | PubMed |
| Integrative analysis of Anoikis-related genes reveals that FASN is a novel prognostic biomarker and promotes the malignancy of bladder cancer via Wnt/β-catenin pathway. | Heliyon | 2024 | 39071712 | PubTator, text mining | PubMed |
| Role of microRNAs in Diabetes-Associated Periodontitis: A Scoping Review. | J Int Soc Prev Community Dent | 2024 | 39055291 | PubTator, text mining | PubMed |
| SIRT6 Inhibits the Proliferation and Collagen Synthesis of Keloid Fibroblasts through MAPK/ERK Pathway. | Discov Med | 2024 | 39054714 | PubTator, text mining | PubMed |
| Epigenetic and transcriptional control of adipocyte function by centenarian-associated SIRT6 N308K/A313S mutant. | Clin Epigenetics | 2024 | 39033117 | PubTator, text mining | PubMed |
| Impaired autophagy-mediated macrophage polarization contributes to age-related hyposalivation. | Cell Prolif | 2024 | 39004782 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51548/papers?page=18